Differences in lung bioavailability between HFA and CFC formulations of fluticasone propionate

Wilson, Andrew M. ORCID: https://orcid.org/0000-0002-5514-4867, Sims, Erika J., Orr, Linda C. and Lipworth, Brian J. (1999) Differences in lung bioavailability between HFA and CFC formulations of fluticasone propionate. Lancet, 354 (9187). pp. 1357-1358. ISSN 1474-547X

Full text not available from this repository. (Request a copy)

Item Type:	Article
Additional Information:	Source:RK Note:
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Respiratory and Airways Group Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Centres > Population Health (former - to 2025) Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:12
Last Modified:	28 Oct 2026 16:22
URI:	https://ueaeprints.uea.ac.uk/id/eprint/14705
DOI:	10.1016/S0140-6736(99)03581-3

Actions (login required)

View Item